Clinical Trial

The Efficacy and Safety of Precision REpetitive Transcranial Magnetic Stimulation in Alleviating Motor Symptom in Parkinson's Disease

Recruiting
View on ClinicalTrials.gov →
Summary
Repetitive transcranial magnetic stimulation (rTMS) is a non-invasive and widely used neuromodulation technology. Small sample studies have shown that rTMS treatment can significantly improve the symptoms of Parkinson's disease(PD) and delay the progression of the disease. In order to further explore the effectiveness of rTMS in the treatment of PD and lay the foundation for its clinical promotion, our research team plans to conduct a randomized double-blind controlled study of rTMS in the treatment of PD in multiple centers across the country.
Protocol Amendment History 4 amendments
This ClinicalTrials.gov record has been amended 4 times since 2024-04-22; most recent amendment 2025-06-14.
Status change: Not Yet Recruiting → Recruiting 2025-03-07
Trial Details
NCT Number NCT06383247
Lead Sponsor Anhui Medical University
Conditions Parkinson Disease, Transcranial Magenetic Stimualtion, Supplementary Motor Area
Enrollment 290 participants
Start Date 2024-12-06
Primary Completion 2026-12-31 (estimated)
Study Completion 2028-12-31 (estimated)
Updated on ClinicalTrials.gov 2025-06-17